tetracyclines articles ↓

In contrast to the ongoing disputes over generic Oracea, the makers of the low-dose minocycline Solodyn, Medicis have entered into a joint development and sales agreement with Lupin Pharmaceuticals. …

Documents recently filed in the Mylan vs. Galderma patent litigation reveal that Mylan Pharmaceuticals continues to argue that it should be allowed to manufacture generic Oracea. This ongoing battle is known as the “Oracea Patent Litigation”.

If you are interested to see how generic pharma takes on big pharma to get a …

This just published abstract is looking at recent advances in the use of the tetracycline family in treating rosacea. Of course a lot of the interest in subantimicrobial dose doxycyline has been motivated by the introduction of the Oracea to the market.

A previous published study instigated by Collagenex (now owned by Galderma) showed that 100mg doxycycline was no better than oracea in treating the …

Reading this just published abstract highlights for me just how slowly indeed research moves along. These recently proposed methods of action of tetracyclines seem to embody far from ground breaking research. We learnt in 2007 that tetracyclines have anti-inflammatory actions:  “Tetracyclines are known to exhibit multiple significant anti-inflammatory actions … the mechanisms of this anti-inflammatory activity, such as inhibition of chemotaxis, granuloma formation, …

If you have trouble swallowing tablets, here is an official FDA sanctioned tip. Open the tablet and sprinkle the delayed release pellets on to a spoonful of applesauce. This is a good option for anyone who finds swallowing the …